Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Paclitaxel
100%
Multicellular Spheroids
100%
Exposure Parameters
100%
Drug Exposure
100%
DLD-1
42%
Solid Tumors
42%
IC50
28%
MCF-7
28%
Cell Killing
28%
IC50 Value
14%
Cell-to-cell
14%
Human Colon Carcinoma
14%
Human Breast Carcinoma
14%
Tirapazamine
14%
Synergistic Effect
14%
Exposure Time
14%
Avascular
14%
Bioreductant
14%
Multi-cell
14%
MCF-7 Cells
14%
Clinical Activity
14%
Monolayer Culture
14%
Preclinical Evaluation
14%
Combination Therapy
14%
Plateau Phase
14%
Prolonged Infusion
14%
Dose-response Curve
14%
Tumor Blood Vessels
14%
Taxol
14%
Sensitive Phase
14%
Overall Concentrations
14%
Exposure Concentration
14%
Metastatic Breast Cancer
14%
Micro-region
14%
Cell Cycle Phases
14%
C(X)
14%
Phase-specific
14%
Pharmacology, Toxicology and Pharmaceutical Science
Paclitaxel
100%
IC50
37%
Solid Malignant Neoplasm
37%
Breast Carcinoma
12%
Colon Carcinoma
12%
Antiinfective Agent
12%
Tirapazamine
12%
Combination Therapy
12%
Vascular Tumor
12%
Metastatic Breast Cancer
12%